131802-69-2 Usage
Uses
Used in Pharmaceutical Industry:
3-hydroxy-3-phenylpentamide is used as a potential active pharmaceutical ingredient for its unique chemical structure, which may offer novel therapeutic benefits. Its specific properties, including the hydroxy and phenyl groups, could be leveraged to develop new drugs or enhance existing ones.
Used in Medical Research:
In the medical research field, 3-hydroxy-3-phenylpentamide is utilized as a subject of study to understand its interactions with biological systems. This could lead to insights into new treatment methods or diagnostic tools based on its chemical reactivity and binding affinities.
Used in Drug Development:
3-hydroxy-3-phenylpentamide is employed as a lead compound in drug development processes. Its structural features may be optimized to create new molecules with improved pharmacological profiles, targeting specific diseases or conditions more effectively.
Check Digit Verification of cas no
The CAS Registry Mumber 131802-69-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,1,8,0 and 2 respectively; the second part has 2 digits, 6 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 131802-69:
(8*1)+(7*3)+(6*1)+(5*8)+(4*0)+(3*2)+(2*6)+(1*9)=102
102 % 10 = 2
So 131802-69-2 is a valid CAS Registry Number.
InChI:InChI=1/C11H15NO2/c1-2-11(14,8-10(12)13)9-6-4-3-5-7-9/h3-7,14H,2,8H2,1H3,(H2,12,13)
131802-69-2Relevant academic research and scientific papers
A new homologous series of anticonvulsants: Phenyl alcohol amides. Synthesis and pharmacological evaluation
Mezo-Toledo,Zenteno-Garcia,Juarez-Carvajal,Martinez-Munoz,Carvajal-Sandoval
, p. 1289 - 1291 (2007/10/02)
The anticonvulsant activity of a homologous series of phenyl alcohol amides is described. (±)-2-Hydroxy-2-phenylbutyramide (1), (±)-3-hydroxy-3-phenylpentanamide (2) and (±)-4-hydroxy-4-phenylhexanamide (3) were prepared and tested for their anticonvulsant profile and neurotoxicity. 1, 2 and 3 exhibited a broad profile of anticonvulsant activity and a similar significant activity in the seizures provoked by maximal electroshock, pentetrazol, 4-aminopyridine, bicuculline and thiosemicarbazide, but in the strychnine and picrotoxin tests, the protection was variable. The rotarod ataxia test was used to evaluate their neurotoxicity. In this test 2 possesses the lowest neurotoxicity.
